Robert W. Seabury

684 total citations
50 papers, 367 citations indexed

About

Robert W. Seabury is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Robert W. Seabury has authored 50 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 11 papers in Infectious Diseases and 11 papers in Epidemiology. Recurrent topics in Robert W. Seabury's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Bacterial Identification and Susceptibility Testing (8 papers). Robert W. Seabury is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Bacterial Identification and Susceptibility Testing (8 papers). Robert W. Seabury collaborates with scholars based in United States. Robert W. Seabury's co-authors include Jeffrey M. Steele, Christopher D. Miller, William Darko, Wesley D. Kufel, Bryan T. Mogle, Christopher Miller, Utkarsh J. Dang, Stephanie Zyck, Satish Krishnamurthy and Ross Sullivan and has published in prestigious journals such as Critical Care Medicine, International Journal of Antimicrobial Agents and Clinical Therapeutics.

In The Last Decade

Robert W. Seabury

43 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert W. Seabury United States 11 144 142 102 81 65 50 367
William Darko United States 10 96 0.7× 86 0.6× 63 0.6× 64 0.8× 78 1.2× 38 311
Melanie Smith United States 10 177 1.2× 201 1.4× 62 0.6× 199 2.5× 93 1.4× 33 543
Andrew C. Faust United States 11 66 0.5× 102 0.7× 51 0.5× 108 1.3× 54 0.8× 33 398
Darrel W. Hughes United States 13 68 0.5× 132 0.9× 56 0.5× 118 1.5× 39 0.6× 16 374
Wasim S. El Nekidy United States 10 56 0.4× 124 0.9× 27 0.3× 63 0.8× 19 0.3× 52 284
William Peppard United States 15 65 0.5× 145 1.0× 42 0.4× 177 2.2× 51 0.8× 54 646
Christian Lanckohr Germany 12 104 0.7× 92 0.6× 65 0.6× 104 1.3× 12 0.2× 29 347
Deonne Dersch‐Mills Canada 14 141 1.0× 160 1.1× 64 0.6× 85 1.0× 10 0.2× 49 546
Chad A. Knoderer United States 14 299 2.1× 147 1.0× 45 0.4× 193 2.4× 98 1.5× 46 660
Heather A. Personett United States 11 77 0.5× 104 0.7× 10 0.1× 155 1.9× 37 0.6× 24 391

Countries citing papers authored by Robert W. Seabury

Since Specialization
Citations

This map shows the geographic impact of Robert W. Seabury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Seabury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Seabury more than expected).

Fields of papers citing papers by Robert W. Seabury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Seabury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Seabury. The network helps show where Robert W. Seabury may publish in the future.

Co-authorship network of co-authors of Robert W. Seabury

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Seabury. A scholar is included among the top collaborators of Robert W. Seabury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Seabury. Robert W. Seabury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, Christopher D., et al.. (2025). Retrospective analysis of low-dose versus higher-dose haloperidol in older emergency department patients. The American Journal of Emergency Medicine. 92. 37–42.
2.
Kufel, Wesley D., et al.. (2025). Impact of Remdesivir on Heart Rate and Bradycardia Incidence Among Hospitalized Adults With COVID-19. Annals of Pharmacotherapy. 59(12). 1086–1093. 2 indexed citations
3.
Kufel, Wesley D., Robert W. Seabury, Jason C Gallagher, et al.. (2024). Let's Have a Chat: How Well Does an Artificial Intelligence Chatbot Answer Clinical Infectious Diseases Pharmacotherapy Questions?. Open Forum Infectious Diseases. 11(11). ofae641–ofae641. 5 indexed citations
4.
5.
Seabury, Robert W., et al.. (2023). Preparation/administration of push-dose versus continuous infusion epinephrine and phenylephrine: A simulation. The American Journal of Emergency Medicine. 74. 135–139.
6.
Kufel, Wesley D., et al.. (2023). Impact of a Pharmacist-Conducted Preoperative Beta-Lactam Allergy Assessment on Perioperative Cefazolin Prescribing. Journal of Pharmacy Practice. 37(5). 1073–1081.
7.
Kufel, Wesley D., et al.. (2023). Real-world evaluation of linezolid-associated serotonin toxicity with and without concurrent serotonergic agents. International Journal of Antimicrobial Agents. 62(1). 106843–106843. 7 indexed citations
8.
9.
10.
Seabury, Robert W., et al.. (2022). Does a Positive Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screen Predict the Risk for MRSA Skin and Soft Tissue Infection?. Annals of Pharmacotherapy. 57(6). 669–676. 3 indexed citations
11.
Seabury, Robert W., Stephanie Zyck, Christopher D. Miller, et al.. (2022). Andexanet alfa effectiveness and safety versus four-factor prothrombin complex concentrate (4F-PCC) in intracranial hemorrhage while on apixaban or rivaroxaban: A single-center, retrospective, matched cohort analysis. The American Journal of Emergency Medicine. 55. 16–19. 22 indexed citations
12.
Darko, William, Robert W. Seabury, Christopher D. Miller, et al.. (2021). Implementation of a formal pharmacy residency research certificate program. American Journal of Health-System Pharmacy. 78(5). 436–446. 8 indexed citations
13.
Kufel, Wesley D., et al.. (2021). Hospital Discharge: An Opportune Time for Antimicrobial Stewardship. Annals of Pharmacotherapy. 56(8). 869–877. 11 indexed citations
14.
Fazili, Tasaduq, Dongliang Wang, Jeffrey M. Steele, et al.. (2020). Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(4). 357–362. 15 indexed citations
15.
Seabury, Robert W., et al.. (2020). Cost comparison of AUC:MIC– versus trough-based vancomycin monitoring for MRSA bacteremia. Journal of the American Pharmacists Association. 60(5). 729–733. 2 indexed citations
16.
17.
Seabury, Robert W., William Darko, Christopher D. Miller, Jeffrey M. Steele, & Wesley D. Kufel. (2019). Publications for Pharmacy Residents Are Challenging but Not “Nearly Unattainable”. Hospital Pharmacy. 55(3). 153–153. 2 indexed citations
18.
Mogle, Bryan T., Jeffrey M. Steele, Robert W. Seabury, Utkarsh J. Dang, & Wesley D. Kufel. (2018). Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia. International Journal of Antimicrobial Agents. 52(6). 805–810. 44 indexed citations
19.
Mogle, Bryan T., et al.. (2018). The Culture of Carbapenem Overconsumption: Where Does It Begin? Results of a Single-Center Survey. Hospital Pharmacy. 54(3). 175–179.
20.
Steele, Jeffrey M., et al.. (2017). Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin. Journal of Clinical Pharmacy and Therapeutics. 43(1). 101–103. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William Darko Breakdown of academic impact, for papers by Melanie Smith Breakdown of academic impact, for papers by Andrew C. Faust Breakdown of academic impact, for papers by Darrel W. Hughes Breakdown of academic impact, for papers by Wasim S. El Nekidy Breakdown of academic impact, for papers by William Peppard Breakdown of academic impact, for papers by Christian Lanckohr Breakdown of academic impact, for papers by Deonne Dersch‐Mills Breakdown of academic impact, for papers by Chad A. Knoderer Breakdown of academic impact, for papers by Heather A. Personett
Rankless by CCL
2026